The FDA's April 2017 Conference on Renal Transplant Rejection

Note:  This a side blog.   For my regular policy blog, see:  www.discoveriesinhealthpolicy.com . 

# # #

The incidence of end stage renal disease is high and rising in the US, there is a shortage of donor kidneys, and too many transplanted organs are lost to organ failure and rejection.

In April 2017, the FDA held a two day conference on the topic.

The FDA home page for the conference is here (some two dozen decks and full transcripts).

Because it's tedious to download every link individually to your hard drive, I had to do it, and I've put a full zip file of about 30 documents in the cloud as open access, here.

See an open-access 8 page conference report, here.